BiotechTV - News cover image

Monte Rosa Therapeutics announced data for MRT-8102, its NEK7-directed molecular glue degrader, showing positive impact on biomarkers linked to atherosclerotic cardiovascular disease

BiotechTV - News

00:00

Monte Rosa’s Expanding Clinical Pipeline

Markus Warmuth previews upcoming trials for partnered autoimmune programs, oncology asset MRT-2359, and new CDK2-Cyclin E1 programs entering the clinic.

Play episode from 18:26
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app